Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Republicans Renew Push To Repeal Device Tax; Broad Support Questionable

This article was originally published in The Pink Sheet Daily

Executive Summary

GOP members in the House and Senate introduced companion bills Jan. 25 that would repeal the medical device excise tax before it takes effect in 2013, but few Democrats have jumped on board publicly so far.

You may also be interested in...



Obama's 2012 Budget To Address Biomed Innovation, But Details Are Lacking

In his annual State of the Union address Jan. 25, the president announced that his proposed federal budget for 2012 will include policies to promote biomedical innovation, but he did not describe what those policies would include.

Health Screening Funds: Possible Pay-For Target For "1099" Tax Rule Repeal?

While a House-approved bill to repeal the entire health care reform law will be dead-on-arrival due to Democratic control of the Senate and White House, there is some bipartisan support for reversing one unpopular provision of the reform law that requires extra tax filings by companies.

Modified Device Tax Remains In Industry's Sights In Post-Election Setting

The results of the 2010 congressional election give some in industry hope that the device excise tax written into the health care reform law can be at least modified in the next Congress before it takes effect.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071772

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel